VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 188 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $397,833 | -7.9% | 92,091 | +40.5% | 0.00% | 0.0% |
| Q2 2023 | $431,889 | +286.6% | 65,537 | +333.5% | 0.00% | – |
| Q4 2022 | $111,729 | -2.0% | 15,119 | +50.0% | 0.00% | – |
| Q1 2022 | $114,000 | -91.8% | 10,076 | -88.6% | 0.00% | -100.0% |
| Q4 2021 | $1,384,000 | +91.4% | 88,193 | +109.2% | 0.00% | +100.0% |
| Q3 2021 | $723,000 | +8.9% | 42,161 | +36.6% | 0.00% | -33.3% |
| Q2 2021 | $664,000 | +187.4% | 30,866 | +100.6% | 0.00% | +200.0% |
| Q1 2021 | $231,000 | -36.7% | 15,384 | -44.6% | 0.00% | -66.7% |
| Q4 2020 | $365,000 | -57.9% | 27,782 | -63.3% | 0.00% | -78.6% |
| Q2 2020 | $866,000 | +3.1% | 75,724 | -6.6% | 0.01% | -33.3% |
| Q1 2020 | $840,000 | -56.3% | 81,070 | -30.8% | 0.02% | +90.9% |
| Q4 2019 | $1,924,000 | -43.9% | 117,229 | -54.6% | 0.01% | -64.5% |
| Q3 2019 | $3,430,000 | +192.9% | 258,316 | +210.8% | 0.03% | +181.8% |
| Q2 2019 | $1,171,000 | -78.6% | 83,103 | -72.0% | 0.01% | -81.0% |
| Q1 2019 | $5,462,000 | +29.1% | 296,868 | +83.4% | 0.06% | +18.4% |
| Q4 2018 | $4,230,000 | +71.3% | 161,884 | +50.4% | 0.05% | +63.3% |
| Q3 2018 | $2,470,000 | +34.2% | 107,615 | +11.4% | 0.03% | +25.0% |
| Q2 2018 | $1,840,000 | +11.7% | 96,600 | -1.3% | 0.02% | -7.7% |
| Q1 2018 | $1,648,000 | +143.1% | 97,827 | +119.4% | 0.03% | +116.7% |
| Q4 2017 | $678,000 | -13.2% | 44,594 | +2.2% | 0.01% | -20.0% |
| Q3 2017 | $781,000 | +251.8% | 43,647 | +220.9% | 0.02% | +275.0% |
| Q2 2017 | $222,000 | -46.0% | 13,600 | -53.7% | 0.00% | -63.6% |
| Q1 2017 | $411,000 | -30.7% | 29,376 | -21.0% | 0.01% | -54.2% |
| Q4 2016 | $593,000 | +177.1% | 37,200 | +45.3% | 0.02% | +41.2% |
| Q1 2016 | $214,000 | -5.3% | 25,600 | +5.3% | 0.02% | -32.0% |
| Q4 2015 | $226,000 | +76.6% | 24,300 | +76.1% | 0.02% | -44.4% |
| Q1 2015 | $128,000 | – | 13,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |